1. Home
  2. QUIK vs CDXS Comparison

QUIK vs CDXS Comparison

Compare QUIK & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$14.52

Market Cap

236.6M

Sector

Technology

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.47

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
CDXS
Founded
1988
2002
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Major Chemicals
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
236.6M
256.3M
IPO Year
1997
2008

Fundamental Metrics

Financial Performance
Metric
QUIK
CDXS
Price
$14.52
$1.47
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
268.7K
1.3M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.82
EPS
N/A
N/A
Revenue
$20,112,000.00
$138,590,000.00
Revenue This Year
$75.17
$7.73
Revenue Next Year
$16.04
$14.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.30
52 Week Low
$4.80
$0.96
52 Week High
$24.33
$3.87

Technical Indicators

Market Signals
Indicator
QUIK
CDXS
Relative Strength Index (RSI) 45.74 30.27
Support Level $11.76 $1.17
Resistance Level $22.71 $1.92
Average True Range (ATR) 0.93 0.10
MACD 0.33 -0.02
Stochastic Oscillator 71.34 10.88

Price Performance

Historical Comparison
QUIK
CDXS

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: